Characterization of Neisseria meningitidis strains isolated from carriers in Cuba during 20 years;Caracterización de cepas de Neisseria meningitidis aisladas de portadores en Cuba durante 20 años

Revista Cubana de Medicina Tropical

Volumn 58, Issue 2, 2006, Pages

  Motas, Isabel Martínez ^a,b   González, Gustavo Sierra ^a   Gutiérrez, Niury Núñez ^a   Pérez, Luis Izquierdo ^a   Ruíz, Yanet Climent ^a   Sosa, Mayelin Mirabal ^a  

^a FINLAY INSTITUTE   (Cuba)

^b Centro de Investigación Producción de Vacunas   (Cuba)

Author keywords

Antimeningococcal vaccine; Asymptomatic carriers; Epidemiological markers; Neisseria meningitidis; Phenotypes

Indexed keywords

EID: 33845420612     PISSN: 03750760     EISSN: 15613054     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Yazdankhah SP, Caugant DA. Neisseria meningitidis: an overview of the carriage state. J Med Microbiol 2004;53:821-32.
2. Rosenstein EN, Perkins BA, Stephens DS, Popovic T, Hughes JM Meningococcal disease. N Engl J Med 2001;344:1378-86.
3. Jolley KA, Kalmusova J, Feil EJ, Gupta S,. Musilek M, Kriz P et al. Carried meningococci in the Czech Republic: a diverse recombining population. J Clin Microbiol. 2000;38:4492-8.
4. Pichichero ME. Meningococcal conjugate vaccines. Expert Opin Biol Ther 2005;5:1475-89.
5. Sierra GV, Campa HC, Valcárcel NM, García IL, Izquierdo PL, Sotolongo PF et al. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann 1991;14:195-207.
6. Frasch CE, Zollinger WD, Poolman JT. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis 1985;7:504-10.
7. Kuipers B, van den Dobbelsteen G, Wedege E, van Alphen L. Serological characterization. In: Pollard AJ, Maiden MC, eds. Meningococcal disease: methods and protocols. Totowa (NJ): Humana Press; 2001. p.131-45.
8. Yazdankhah SP, Kriz P, Tzanakaki G, Kremastinou J, Kalmusova J, Musilek M, et al. Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol 2004;42:5144-53.
9. Valcárcel NM, Rodríguez CR, Molinert HT. La enfermedad meningocócica en Cuba. Cronología de una epidemia. 1ra. ed. La Habana: Ed. Ciencias Médicas;1991.
10. Pérez Rodríguez A, Dickinson F, Baly A, Martínez R. The epidemiological impact of antimeningococcal vaccination in Cuba. Mem Inst Oswaldo Cruz 1999;94:433-40.
11. Estadísticas de Salud de Cuba. Anuario Estadístico de Salud 2004. Incidencia y mortalidad por enfermedad meningocócica.1980-2004. Disponible en: http://bvs.sld.cu/anuario/tablas/%20ANUARIOCU1.1-1262.htm
12. Knapp JS, Koumans EH. Neisseria and Branhamella. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. eds. Manual of Clinical Microbiology. 7th ed. Washington D.C.:ASM Press; 1999; p.586-603.
13. Abdillahi H, Poolman JT. Whole cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 1987;48:367-71.
14. Caugant DA, Frohølm LO, Bøvre K, Holten E, Frasch CE, Mocca LS, et al. Intercontinental spread of Neisseria meningitidis clones of the ET-5 complex. Antonie van Leeuwenhoek J Microbiol 1987;53:389-94.
15. Diermayer D, Hedberg K, Hoesly F, Fischer M, Perkins B, Reeves M, et al. Epidemic serogroup B meningococcal disease in Oregon: The evolving epidemiology of the ET-5 strain. JAMA 1999;281:1493-7.
16. Caugant D. Populations genetics and molecular epidemiology of Neisseria meningitidis. APMIS 1998;106:505-25.
17. Riou JY, Poolman JT, Auriol J, Lomprez F, Guibourdenche M. Sero-subtyping of group B, C Y and A meningococci isolated in France 1988. Ann Biol Clin 1990;48:227-32.
18. Vázquez JA. Infección meningocócica. Informe del Laboratorio Nacional de Referencia de Meningococo. Años 1989-1992. Bol Epidemiol Microbiol 1993;1:209-11.
19. Sacchi CT, Lemos AP, Popovic T, de Morais JC, Whitney AM, Melles CE, et al. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997-1998: Overview and implications for vaccine development. J Clin Microbiol 2001;39:2897-903.
20. Castillo L, Maldonado A, García J, Silva W, Ulloa MT, Valenzuela MT, et al. Caracterización de Neisseria meningitidis aisladas de infecciones sistémicas. Chile 1992-1993. Rev Med Chile 1994;122:760-7.
21. Echeverry ML, Malberty JA, Galeano ML, Sotolongo PF, Galguera MA, Montoya BC, et al. Respuesta inmune humoral al polisacárido capsular de Neisseria meningitidis serogrupo C en un ensayo de vacunación antimeningocócica BC en Antioquia, Colombia. Bol Oficina Sanit Panam 1995;118:295-301.
22. Tondella ML, Popovic T, Rosenteins NE, Lake DB, Carlone GM, Mayer LW, et al. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. J Clin Microbiol 2000;38:3323-8.
23. Martínez I, López O, Sotolongo F, Mirabal M, Bencomo A. Portadores de Neisseria meningitidis en niños de una escuela primaria. Rev Cub Med Tropical 2003;55:162-8.
24. Antignac A, Ducos-Galand M, Guiyoule A, Pires R, Alonso JM, Taha MK. Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns. Clin Infect Dis 2003;37:912-20.
25. Fernández S, Arreaza L, Santiago I, Malvar A, Berron S, Vázquez JA, et al. Carriage of a new epidemic strain of Neisseria meningitidis with the incidence of meningococcal disease in Galicia, Spain. Epidemiol Infect 1999;123:349-57.
26. Maiden MCJ, Stuart JM, Bramley JC, MacLennan JM, Gray S, Andrew N. Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 2002;359:1829-31.
27. Navarro JA. La inmunización frente a Neisseria meningitidis serogrupo C con vacuna conjugada: siete años de experiencia. Rev Pediatr Aten Primaria 2006;8:65-86.
28. Fernández S, Arreaza L, Santiago I, Malvar A, Berrón S, Vázquez JA, et al. Impact of meningococcal vaccination with combined serogroups A and C polysaccharide vaccine on carriage of Neisseria meningitidis C. J Med Microbiol 2003;52:75-7.
29. Alcalá B, Salcedo C, Arreaza L, Berron S, de la Fuente L, Vázquez JA. The epidemic wave of meningococcal disease in Spain in 1996-1997: probably a consequence of strain displacement. J Med Microbiol 2002;51:102-6.
30. García A, Bordes A, Lafarga B, Vázquez J, López E, García P, et al. Encuesta de portadores de Neisseria meningitidis en el área de salud de Gran Canaria. Rev Esp Salud Pública 2000;74:419-24.
31. Balmer P, Borrow R, Miller E. Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol 2002;51:717-22.
32. Claus H, Maiden MC, Maag R, Frosch M, Vogel U. Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology 2002;148:1813-9.
33. Sacchi CT, de Lemos AP, Camargo MC, Whitney AM, Melles CE, Solari CA. Meningococcal disease caused by Neisseria meningitidis serogroup B serotype 4 in Sao Paulo, Brazil, 1990 to 1996. Rev Inst Med Trop Sao Paulo 1998;40:65-70.
34. Balkhy HH, Memish ZA, Almuneef MA, Osoba AO. Neisseria meningitidis W-135 carriage during the Hajj season 2003. Scand J Infect Dis 2004;36:264-8.
35. Australian Meningococcal Surveillance Programme. Annual report of the Australian Meningococcal Surveillance Programme, 2002. Commun Dis Intell 2003;27:196-208.
36. Devoy AF, Dyet KH, Martin DR. Stability of PorA during a meningococcal disease epidemic. J Clin Microbiol 2005;43:832-37.
37. Ameratunga S, Macmillan A, Stewart J, Scott D, Mulholland K, Crengle S, et al. Evaluating the post-licensure effectiveness of a group B meningococcal vaccine in New Zealand: a multifaceted strategy. Vaccine 2005;23:2231-4.
38. Simmons G, Martin DR, Stewart J, Jones N, Calder L, Bremner D. Carriage of Neisseria meningitidis among household contacts of patients with meningococcal disease in New Zealand. Eur J Clin Microbiol Infect Dis 2001;20:237-42.
39. Fischer M, Carlone GM, Holst J, Williams D, Stephens DS, Perkins BA. Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease. Vaccine 1999;14;17:2377-83.
40. Mastrantonio P, Stefanelli P, Fazio C, Sofia T, Neri A, La Rosa G, et al. Serotype distribution, antibiotic susceptibility, and genetic relatedness of Neisseria meningitidis strains recently isolated in Italy. Cin Infec Dis 2003;36:422-8.
41. Jones DM, Borrow R, Fox AJ, Gray S, Cartwright KA, Poolman JT. The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis. Microb Pathog 1992;3:219-24.
42. Morley SL, Cole MJ, Ison CA, Camaraza MA, Sotolongo F, Anwar N, et al. Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants. Pediatr Infect Dis J 2001;20:1054-61.
43. Tappero JW, Lagos R, Ballesteros AM, Plikaytis B, Williams D, Dykes J, et al.. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA 1999;281:1520-7.
44. Perkins BA, Jonsdottir K, Briem H, Griffiths E, Plikaytis BD, Hoiby EA, et al. Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J Infect Dis 1998;177:683-91.